Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
CALL
SSR Mining
SSRM
$7.6B
| $5.06M | ﹤0.01% |
504,300
-62,200
| -11% | -$574K |
|
|
TPH
3627
DELISTED
Tri Pointe Homes
TPH
| $5.06M | ﹤0.01% |
158,459
+98,500
| +164% | +$3.36M |
|
3628
CALL
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.3B
| $5.06M | ﹤0.01% |
31,500
+13,100
| +71% | +$2.14M |
|
3629
PUT
Alamos Gold
AGI
$15.4B
| $5.05M | ﹤0.01% |
189,000
+96,000
| +103% | +$2.17M |
|
3630
Belden
BDC
$4.5B
| $5.05M | ﹤0.01% |
50,387
+31,969
| +174% | +$3.55M |
|
3631
International Paper
IP
$20.8B
| $5.05M | ﹤0.01% |
94,638
-1,648,969
| -95% | -$90.2M |
|
3632
DoubleVerify
DV
$2.07B
| $5.05M | ﹤0.01% |
377,525
+339,182
| +885% | +$6.28M |
|
3633
PUT
Procore
PCOR
$9.68B
| $5.04M | ﹤0.01% |
76,400
-146,600
| -66% | -$11.1M |
|
|
FITB
3634
Fifth Third Bancorp
FITB
$49.5B
| $5.04M | ﹤0.01% |
128,580
-170,021
| -57% | -$7.17M |
|
3635
Toro Company
TTC
$9.43B
| $5.04M | ﹤0.01% |
69,260
+41,904
| +153% | +$3.31M |
|
3636
PUT
Eldorado Gold
EGO
$11.9B
| $5.04M | ﹤0.01% |
299,400
+49,800
| +20% | +$748K |
|
|
ECG
3637
Everus Construction Group
ECG
$5.91B
| $5.03M | ﹤0.01% |
135,727
+115,589
| +574% | +$6.22M |
|
3638
PUT
OSI Systems
OSIS
$3.29B
| $5.03M | ﹤0.01% |
25,900
+12,200
| +89% | +$2.32M |
|
3639
CALL
ProShares Ultra Semiconductors
USD
$2.6B
| $5.03M | ﹤0.01% |
249,400
+85,800
| +52% | +$2.46M |
|
3640
CALL
MicroSectors FANG+ ETNs due Jan 8 2038
FNGS
$606M
| $5.03M | ﹤0.01% |
100,900
+69,300
| +219% | +$3.9M |
|
3641
PUT
Scholar Rock
SRRK
$7.04B
| $5.03M | ﹤0.01% |
156,300
-154,200
| -50% | -$5.93M |
|
3642
Kontoor Brands
KTB
$4.21B
| $5.02M | ﹤0.01% |
78,299
+50,789
| +185% | +$3.94M |
|
3643
CALL
iShares MSCI United Kingdom ETF
EWU
$3.81B
| $5.02M | ﹤0.01% |
134,000
+58,900
| +78% | +$2.13M |
|
3644
Mueller Water Products
MWA
$3.81B
| $5.02M | ﹤0.01% |
197,339
-122,897
| -38% | -$3.08M |
|
3645
PUT
Krystal Biotech
KRYS
$10.4B
| $5.01M | ﹤0.01% |
27,800
-59,400
| -68% | -$9.99M |
|
3646
NCR Atleos
NATL
$3.42B
| $5.01M | ﹤0.01% |
189,991
+2,475
| +1% | +$73.6K |
|
3647
CALL
Lightbridge
LTBR
$283M
| $5.01M | ﹤0.01% |
671,300
+520,900
| +346% | +$4.63M |
|
3648
CALL
CVR Energy
CVI
$4.2B
| $5.01M | ﹤0.01% |
258,100
-8,300
| -3% | -$162K |
|
3649
CALL
Vaxcyte
PCVX
$8.9B
| $5.01M | ﹤0.01% |
132,600
-50,800
| -28% | -$4.06M |
|
3650
NMI Holdings
NMIH
$3.37B
| $5M | ﹤0.01% |
138,829
+96,601
| +229% | +$3.51M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.